Clinical Trial Update: Low-dose RAD001(Everolimus) Plus Cisplatin-HDFL Chemotherapy for the First-line Treatment of Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

This is a Phase 2 trial evaluating low-dose everolimus (RAD001) in combination with cisplatin-based chemotherapy as first-line treatment for metastatic gastric …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Everolimus (everolimus)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Metastatic Gastric Cancer | Phase 2 | Status: COMPLETED